Overview

Cardiovascular Function in COPD Patients

Status:
Completed
Trial end date:
2018-03-26
Target enrollment:
Participant gender:
Summary
The objectives of the study are to explore the effect of treatment with tiotropium + olodaterol fixed dose combination (FDC) compared to fluticasone propionate + salmeterol FDC on: - reversal of left ventricular diastolic dysfunction assessed with cardiac magnetic resonance (CMR) imaging, - measures of arterial stiffness assessed by CMR and pulse wave analysis (PWA), - reduction of hyperinflation assessed with body plethysmography and - post dose spirometry.
Phase:
Phase 4
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Fluticasone
Olodaterol
Salmeterol Xinafoate
Tiotropium Bromide
Xhance